US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

32.14

+0.13000.41%

Pre-market: 32.10-0.0400-0.12%08:00 EDT

Volume:2.00M

Turnover:64.05M

Market Cap:3.87B

PE:-10.61

High:32.48

Open:32.07

Low:31.41

Close:32.01

Loading ...

Overview Company News Filings

Avidity Completes Enrollment in Del-brax Trial's Biomarker Group for Facioscapulohumeral Muscular Dystrophy

MT Newswires Live

Avidity Biosciences Inc: Regulatory Alignment on Global Phase 3 Del-Brax Trial Design and Study Initiation Anticipated in Q2 2025

THOMSON REUTERS

Avidity Biosciences Inc: Plan to Present Topline Data From Fortitude Dose Escalation Cohorts in Q2 2025

THOMSON REUTERS

Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 Fortitude™ Trial for Delpacibart Braxlosiran (Del-Brax) in People Living With Facioscapulohumeral Muscular Dystrophy

THOMSON REUTERS

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Circio Advances RNA Platform and Strengthens Financial Position

Avidity Biosciences announces inducement grants under Nasdaq listing rule 5635(C)(4)

Avidity Biosciences’ Promising Developments in DMD Treatment and Strategic Preparations for Future Success

Buy Rating for Avidity Biosciences Driven by Strategic Leadership and Patient-Centric Approach

Avidity Biosciences Price Target Maintained With a $72.00/Share by HC Wainwright & Co.

Press Release: Korro Reports Full Year 2024 Financial Results and Provides Business Updates

Optimistic Buy Rating for Avidity Biosciences Driven by Promising DMD Treatment and Strategic Expansion Plans

Promising Trial Results and Strong Growth Potential Lead to Buy Rating for Avidity Biosciences

Avidity Biosciences Is Maintained at Buy by Chardan Capital

Sector Update: Health Care Stocks Decline Premarket Monday

MT Newswires Live

Avidity Biosciences Reports Positive Topline Data From Phase 1/2 Trial of Del-Zota to Treat DMD

MT Newswires Live

Avidity Biosciences Announces Positive EXPLORE44 Trial Results

BRIEF-Avidity Biosciences Announces Positive Topline Del-Zota Data In DMD44 Trial

Avidity Biosciences Inc - on Track for Year-End 2025 Bla Submission for Del-Zota in Dmd44

THOMSON REUTERS

KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RNA/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","market":"US","secType":"STK","nameCN":"Avidity Biosciences, Inc.","latestPrice":32.14,"timestamp":1749758400000,"preClose":32.01,"halted":0,"volume":1999680,"hourTrading":{"tag":"盘前","latestPrice":32.1,"preClose":32.14,"latestTime":"08:00 EDT","volume":147,"amount":4713.7990199999995,"timestamp":1749816012663},"delay":0,"floatShares":91767817,"shares":120538359,"eps":-3.028277,"marketStatus":"Pre-Mkt","change":0.13,"latestTime":"06-13 08:43:08 EDT","open":32.07,"high":32.48,"low":31.41,"amount":64054737.60192,"amplitude":0.033427,"askPrice":32.1,"askSize":12,"bidPrice":31,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-3.028277,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749821400000},"marketStatusCode":1,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":32.14,"preHourTrading":{"tag":"盘前","latestPrice":32.1,"preClose":32.14,"latestTime":"08:00 EDT","volume":147,"amount":4713.7990199999995,"timestamp":1749816012663},"postHourTrading":{"tag":"盘后","latestPrice":32.14,"preClose":32.14,"latestTime":"18:02 EDT","volume":324090,"amount":10416252.6,"timestamp":1749765737234},"volumeRatio":0.8874194027945933,"impliedVol":0.4651,"impliedVolPercentile":0.0683},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","floatShares":91767817,"roa":"-22.47%","roe":"-34.19%","lyrEps":-2.888476,"volumeRatio":0.8874194027945933,"shares":120538359,"dividePrice":0,"high":32.48,"amplitude":0.033427,"preClose":32.01,"low":31.41,"week52Low":21.51,"pbRate":"2.92","psRate":"433.98","week52High":56,"institutionHeld":0,"latestPrice":32.14,"committee":-0.846154,"eps":-3.028277,"divideRate":0,"volume":1999680,"delay":0,"ttmEps":-3.028277,"open":32.07,"prevYearClose":29.08,"prevWeekClose":36.24,"prevMonthClose":30.98,"prevQuarterClose":29.52,"fiveDayClose":35.59,"twentyDayClose":28.4,"sixtyDayClose":30.48},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNA\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523925294","title":"Avidity Completes Enrollment in Del-brax Trial's Biomarker Group for Facioscapulohumeral Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2523925294","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523925294?lang=en_us&edition=fundamental","pubTime":"2025-03-31 22:55","pubTimestamp":1743432938,"startTime":"0","endTime":"0","summary":"Avidity Biosciences (RNA) said Monday it completed enrollment in the biomarker group in a phase 1/2 trial of delpacibart braxlosiran, or del-brax, in people with facioscapulohumeral muscular dystrophy","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4139","BK4585","RNA","BK4505"],"gpt_icon":0},{"id":"2523941279","title":"Avidity Biosciences Inc: Regulatory Alignment on Global Phase 3 Del-Brax Trial Design and Study Initiation Anticipated in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523941279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523941279?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:01","pubTimestamp":1743426080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0Y2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNA","BK4588","BK4505","BK4139","BK4585"],"gpt_icon":0},{"id":"2523941274","title":"Avidity Biosciences Inc: Plan to Present Topline Data From Fortitude Dose Escalation Cohorts in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523941274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523941274?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:01","pubTimestamp":1743426080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0Y2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","RNA","BK4139","BK4505","BK4585"],"gpt_icon":0},{"id":"2523941270","title":"Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 Fortitude™ Trial for Delpacibart Braxlosiran (Del-Brax) in People Living With Facioscapulohumeral Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2523941270","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523941270?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:01","pubTimestamp":1743426080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4588","BK4585","BK4505","RNA"],"gpt_icon":0},{"id":"2522504802","title":"Promising Genomics & Synthetic Biology Stocks to Consider in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522504802","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522504802?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:39","pubTimestamp":1743169140,"startTime":"0","endTime":"0","summary":"Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary focus is on characterizing all the genes of an organism, rather than individual genes.The evolution of genomics in the last couple of decades to decode diseases has ushered in a revolutionary era in genetic medicine. There have been several breakthroughs in this field, attracting the attention of pharma and biotech companies. Of late, genomic information is being used to evaluate individual responses to drugs and facilitate the development of targeted therapies.Interestingly, genomics has paved the way for innovative concepts like synthetic biology, which applies engineering principles to biology. Synthetic biology products serve life sciences researchers across a variety of healthcare applications, including drug discovery, disease detection, enzyme engineering, gene editing and basic ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/promising-genomics-synthetic-biology-stocks-133900631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2756315664.SGD","LU0942090050.USD","LU0823411888.USD","LU0234572021.USD","LU0868494708.USD","WVE","LU1929549753.HKD","BK4548","LU1162221912.USD","BK4533","IE00BSNM7G36.USD","NTLA","LU1551013425.SGD","BK4535","TWST","LU0943347566.SGD","BEAM","BK4556","NGS","IE00B1XK9C88.USD","ILMN","BK4504","BK4566","HD","LU1861559042.SGD","LU1035775433.USD","IE00BWXC8680.SGD","LU0320765646.SGD","LU0820562030.AUD","BK4179","LU0820561818.USD","LU1861558580.USD","IE00BKVL7J92.USD","LU1674673428.USD","RNA","BK4585","BK4581","SG9999001440.SGD","LU1496350171.SGD","LU1674673691.USD","LU1989772840.SGD","SCD","LU2756315318.SGD","LU1914381329.SGD","LU0079474960.USD","LU0689472784.USD","LU1496350502.SGD","LU0354030511.USD","CRSP","LU0868494617.USD"],"gpt_icon":0},{"id":"2522810953","title":"Circio Advances RNA Platform and Strengthens Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2522810953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522810953?lang=en_us&edition=fundamental","pubTime":"2025-03-26 16:03","pubTimestamp":1742976198,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) has issued an announcement. Circio Holding ASA has announced advancements in its circVec 3.0 RNA therapeutic platform, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-advances-rna-platform-and-strengthens-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-advances-rna-platform-and-strengthens-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","RNA","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2521254666","title":"Avidity Biosciences announces inducement grants under Nasdaq listing rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521254666","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521254666?lang=en_us&edition=fundamental","pubTime":"2025-03-22 04:26","pubTimestamp":1742588766,"startTime":"0","endTime":"0","summary":"March 21 (Reuters) - Avidity Biosciences Inc ::*AVIDITY BIOSCIENCES ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 21-MAR-202520:05:01.937 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nRSD33R2Ny:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","BK4585","BK4505","BK4588","BK4139"],"gpt_icon":0},{"id":"2520892970","title":"Avidity Biosciences’ Promising Developments in DMD Treatment and Strategic Preparations for Future Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2520892970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520892970?lang=en_us&edition=fundamental","pubTime":"2025-03-19 15:56","pubTimestamp":1742370977,"startTime":"0","endTime":"0","summary":"Analyst Joseph Schwartz from Leerink Partners reiterated a Buy rating on Avidity Biosciences (RNA – Research Report) and keeping the price target a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/avidity-biosciences-promising-developments-in-dmd-treatment-and-strategic-preparations-for-future-success?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/avidity-biosciences-promising-developments-in-dmd-treatment-and-strategic-preparations-for-future-success?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4505","BK4139","RNA","BK4585"],"gpt_icon":0},{"id":"2520991098","title":"Buy Rating for Avidity Biosciences Driven by Strategic Leadership and Patient-Centric Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2520991098","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520991098?lang=en_us&edition=fundamental","pubTime":"2025-03-19 13:45","pubTimestamp":1742363108,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Ritu Baral from TD Cowen maintained a Buy rating on Avidity Biosciences (RNA – Research Report), with a price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-avidity-biosciences-driven-by-strategic-leadership-and-patient-centric-approach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-avidity-biosciences-driven-by-strategic-leadership-and-patient-centric-approach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNA"],"gpt_icon":0},{"id":"2520898959","title":"Avidity Biosciences Price Target Maintained With a $72.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520898959","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520898959?lang=en_us&edition=fundamental","pubTime":"2025-03-19 01:11","pubTimestamp":1742317860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2025 13:11 ET (17:11 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA"],"gpt_icon":0},{"id":"2520623331","title":"Press Release: Korro Reports Full Year 2024 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2520623331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520623331?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:00","pubTimestamp":1742295600,"startTime":"0","endTime":"0","summary":"--  Completed dosing of first two cohorts in Phase 1/2a. REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin. --  U.S. Food and Drug Administration  Granted Orphan. programs, targeting two tissue types with a single. Clinical Advisory Board and key additions to board. \"KRRO-110 has best-in-class potential based on our preclinical data, and we are excited to potentially demonstrate this in PiZZ patients in the second half of 2025 with the interim data readout of REWRITE. We also anticipate announcing our second development candidate by the end of 2025. Our strategy of taking three development candidates in two tissue types with a single RNA-editing platform in the clinic by the end of 2027 will expand the possibilities of RNA editing, underscoring our commitment to progressing both our wholly owned and partnered programs.\". to progress enrollment in Australia, and potential expansion into. multiple jurisdictions, including the United States. An interim readout. is expected in the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","LU0170899867.USD","CMC","IE00B1BXHZ80.USD","IE00BKVL7J92.USD","LU0149725797.USD","LU0971096721.USD","IE00BHPRN162.USD","LU1363072403.SGD","BK4099","BK4604","BK4555","RNA","LU0882574139.USD","BK4585","03160","BK4006","TM","BK4588","IE00BZ1G4Q59.USD","BK4139","BK4505","LU0267386448.USD"],"gpt_icon":0},{"id":"2520444649","title":"Optimistic Buy Rating for Avidity Biosciences Driven by Promising DMD Treatment and Strategic Expansion Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2520444649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520444649?lang=en_us&edition=fundamental","pubTime":"2025-03-18 17:55","pubTimestamp":1742291743,"startTime":"0","endTime":"0","summary":"Avidity Biosciences (RNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tazeen Ahmad ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-avidity-biosciences-driven-by-promising-dmd-treatment-and-strategic-expansion-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-avidity-biosciences-driven-by-promising-dmd-treatment-and-strategic-expansion-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNA"],"gpt_icon":0},{"id":"2520722145","title":"Promising Trial Results and Strong Growth Potential Lead to Buy Rating for Avidity Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2520722145","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520722145?lang=en_us&edition=fundamental","pubTime":"2025-03-18 00:15","pubTimestamp":1742228108,"startTime":"0","endTime":"0","summary":"Analyst Joseph Stringer from Needham maintained a Buy rating on Avidity Biosciences (RNA – Research Report) and keeping the price target at $60.00....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-trial-results-and-strong-growth-potential-lead-to-buy-rating-for-avidity-biosciences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-trial-results-and-strong-growth-potential-lead-to-buy-rating-for-avidity-biosciences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNA"],"gpt_icon":0},{"id":"2520520256","title":"Avidity Biosciences Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2520520256","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520520256?lang=en_us&edition=fundamental","pubTime":"2025-03-17 22:17","pubTimestamp":1742221020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 17, 2025 10:17 ET (14:17 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA"],"gpt_icon":0},{"id":"2520529493","title":"Sector Update: Health Care Stocks Decline Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2520529493","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520529493?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:12","pubTimestamp":1742217155,"startTime":"0","endTime":"0","summary":"Health care stocks declined premarket Monday with the Health Care Select Sector SPDR Fund  0.3% lower and the iShares Biotechnology ETF  down 0.9% recently.Avidity Biosciences Inc  shares advanced by over 3% after the company said topline data from the phase 1/2 EXPLORE44 trial of del-zota to treat Duchenne muscular dystrophy showed \"consistent, statistically significant improvements in dystrophin, exon skipping and creatine kinase.\"Dyne Therapeutics  shares were up over 4% after the company said long-term clinical data from an ongoing phase 1/2 clinical trial of its investigational drug DYNE-251 is showing a \"clinically meaningful and sustained functional improvement\" in patients with Duchenne muscular dystrophy.Novartis  is tracking the Trump administration's proposed reciprocal tariff policy \"very carefully\" and will respond accordingly once the policy is implemented next month, Reuters reported, citing Novartis Chief Executive Vas Narasimhan. Novartis shares were over 1% higher pre","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNA","NVS","IBB","LU0208291251.USD","IE00B2B36J28.USD","BK4007","LU0070302665.USD","BK4581","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4578","LU0320765489.SGD","BK4532","BK4585","BK4505","BK4588","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4139","DYN","LU0211331839.USD","IE00BJT1NW94.SGD","XLV","IE0009355771.USD"],"gpt_icon":0},{"id":"2520544243","title":"Avidity Biosciences Reports Positive Topline Data From Phase 1/2 Trial of Del-Zota to Treat DMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2520544243","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520544243?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:35","pubTimestamp":1742211357,"startTime":"0","endTime":"0","summary":"Avidity Biosciences  said Monday that topline data from the phase 1/2 EXPLORE44 trial of del-zota to treat Duchenne muscular dystrophy showed \"consistent, statistically significant improvements in dystrophin, exon skipping and creatine kinase.\"The biopharmaceutical company said del-zota also demonstrated favorable safety and tolerability in the dose cohorts. It also said it will present the data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference this week.Shares of Avidity Biosciences were up 2.9% in recent premarket activity.Price: 32.00, Change: +0.89, Percent Change: +2.86","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4139","BK4585","BK4505","RNA"],"gpt_icon":0},{"id":"2520542781","title":"Avidity Biosciences Announces Positive EXPLORE44 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520542781","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520542781?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:29","pubTimestamp":1742210944,"startTime":"0","endTime":"0","summary":"Avidity Biosciences ( ($RNA) ) has provided an update. On March 17, 2025, Avidity Biosciences announced the topline data from its Phase 1/2 EXPLORE...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avidity-biosciences-announces-positive-explore44-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avidity-biosciences-announces-positive-explore44-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","RNA","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2520497915","title":"BRIEF-Avidity Biosciences Announces Positive Topline Del-Zota Data In DMD44 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2520497915","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520497915?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:12","pubTimestamp":1742209971,"startTime":"0","endTime":"0","summary":"BRIEF-Avidity Biosciences Announces Positive Topline Del-Zota Data In DMD44 TrialMarch 17 (Reuters) - Avidity Biosciences Inc RNA.O:AVIDITY BIOSCIENCES INC - ANNOUNCES POSITIVE TOPLINE DEL-ZOTA DATA I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3PY02N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNA","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"2520039546","title":"Avidity Biosciences Inc - on Track for Year-End 2025 Bla Submission for Del-Zota in Dmd44","url":"https://stock-news.laohu8.com/highlight/detail?id=2520039546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520039546?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:00","pubTimestamp":1742209224,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3PY02N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","BK4139","RNA","BK4505"],"gpt_icon":0},{"id":"2519280346","title":"KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2519280346","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519280346?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:00","pubTimestamp":1741953600,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., March 14, 2025  -- Korro Bio, Inc.  , a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, announced today that the U.S. Food and Drug Administration  has granted orphan drug designation to the investigational medicine KRRO-110 for the treatment of Alpha-1 Antitrypsin Deficiency .“Receiving orphan drug designation from the FDA underscores the growing need for new treatments for patients living with AATD,” said Kemi Olugemo, MD, Chief Medical Officer at Korro. “KRRO-110 has the potential to treat both liver and lung manifestations of AATD, and we are committed to addressing the unmet need and advancing this potentially best-in-class therapy for people living with AATD.”KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERATM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/krro-110-receives-orphan-drug-120000852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4505","RNA","KRRO","BK4139","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":4,"totalSize":161,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"RNA","fiscalQuarterEnding":"2025/03","expectedEps":-0.88,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.9},{"market":"US","date":"2025-02-27","symbol":"RNA","fiscalQuarterEnding":"2024/12","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2024-11-07","symbol":"RNA","fiscalQuarterEnding":"2024/09","expectedEps":-0.79,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-08-09","symbol":"RNA","fiscalQuarterEnding":"2024/06","expectedEps":-0.76,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-05-09","symbol":"RNA","fiscalQuarterEnding":"2024/03","expectedEps":-0.81,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2143,"buy":0.7857,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7857,"analysts":14,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNA","date":"2025-06-11","current":-10.97584,"percent":0.504468,"low":-41.796609,"twenty":-20.292093,"median":-11.015974,"eighty":-5.130468,"high":-1.864956,"avg":-13.084426,"sd":9.15066,"marketCap":4052499629},"quantilePoints":[{"date":"2020-06-12","current":-35.638406,"twenty":-29.775182,"median":-20.980345,"eighty":-20.980345,"marketCap":1007497743},{"date":"2020-06-19","current":-39.899176,"twenty":-39.116319,"median":-35.96886,"eighty":-26.843569,"marketCap":1127949695},{"date":"2020-06-26","current":-35.321452,"twenty":-39.755873,"median":-37.152541,"eighty":-35.448234,"marketCap":998537442},{"date":"2020-07-02","current":-35.653171,"twenty":-39.328619,"median":-36.138594,"eighty":-35.384843,"marketCap":1007915142},{"date":"2020-07-10","current":-35.746052,"twenty":-38.41042,"median":-36.382953,"eighty":-35.641359,"marketCap":1010540898},{"date":"2020-07-17","current":-34.352832,"twenty":-38.00705,"median":-36.138594,"eighty":-35.045462,"marketCap":971154560},{"date":"2020-07-24","current":-31.486779,"twenty":-37.457723,"median":-35.838933,"eighty":-32.192677,"marketCap":890131236},{"date":"2020-07-31","current":-37.404648,"twenty":-37.478953,"median":-36.117578,"eighty":-33.328484,"marketCap":1057429395},{"date":"2020-08-07","current":-38.121161,"twenty":-37.815979,"median":-36.147989,"eighty":-33.816774,"marketCap":1077685226},{"date":"2020-08-14","current":-32.261103,"twenty":-37.539989,"median":-35.87874,"eighty":-32.619559,"marketCap":1087521766},{"date":"2020-08-21","current":-33.897535,"twenty":-37.478953,"median":-35.772589,"eighty":-32.619559,"marketCap":1142685913},{"date":"2020-08-28","current":-31.749022,"twenty":-37.383418,"median":-35.638406,"eighty":-31.8314,"marketCap":1070259516},{"date":"2020-09-04","current":-31.949401,"twenty":-37.295844,"median":-35.095883,"eighty":-31.869249,"marketCap":1077014309},{"date":"2020-09-11","current":-37.281723,"twenty":-37.285229,"median":-35.268377,"eighty":-31.949401,"marketCap":1256766872},{"date":"2020-09-18","current":-38.194563,"twenty":-37.497529,"median":-35.653171,"eighty":-32.060723,"marketCap":1287538709},{"date":"2020-09-25","current":-32.45035,"twenty":-37.497529,"median":-35.645789,"eighty":-32.160913,"marketCap":1093901293},{"date":"2020-10-02","current":-31.860343,"twenty":-37.404648,"median":-35.215302,"eighty":-31.949401,"marketCap":1074012179},{"date":"2020-10-09","current":-30.802785,"twenty":-37.298498,"median":-34.503678,"eighty":-31.871476,"marketCap":1038361879},{"date":"2020-10-16","current":-31.726757,"twenty":-37.285229,"median":-33.897535,"eighty":-31.826947,"marketCap":1069508983},{"date":"2020-10-23","current":-31.125619,"twenty":-37.281723,"median":-33.665444,"eighty":-31.749022,"marketCap":1049244602},{"date":"2020-10-30","current":-27.529919,"twenty":-37.16581,"median":-33.313095,"eighty":-31.613224,"marketCap":928033584},{"date":"2020-11-06","current":-31.147883,"twenty":-37.152541,"median":-33.245062,"eighty":-31.420435,"marketCap":1049995135},{"date":"2020-11-13","current":-28.475809,"twenty":-37.148136,"median":-33.185075,"eighty":-31.147883,"marketCap":1095777625},{"date":"2020-11-20","current":-28.924401,"twenty":-37.112735,"median":-32.711956,"eighty":-30.969768,"marketCap":1113039875},{"date":"2020-11-27","current":-29.967864,"twenty":-36.97474,"median":-32.628465,"eighty":-30.631349,"marketCap":1153193370},{"date":"2020-12-04","current":-31.71347,"twenty":-36.937348,"median":-32.283367,"eighty":-30.353044,"marketCap":1220366040},{"date":"2020-12-11","current":-31.37215,"twenty":-36.722887,"median":-32.366858,"eighty":-30.408705,"marketCap":1207231719},{"date":"2020-12-18","current":-28.007714,"twenty":-36.620708,"median":-32.261103,"eighty":-30.184146,"marketCap":1077764842},{"date":"2020-12-24","current":-28.778121,"twenty":-36.497064,"median":-32.160913,"eighty":-30.079555,"marketCap":1107410880},{"date":"2020-12-31","current":-24.887077,"twenty":-36.316609,"median":-32.105252,"eighty":-29.407768,"marketCap":957679623},{"date":"2021-01-08","current":-27.451851,"twenty":-36.149868,"median":-32.005062,"eighty":-29.207279,"marketCap":1056374662},{"date":"2021-01-15","current":-25.803764,"twenty":-36.130188,"median":-31.860343,"eighty":-29.125292,"marketCap":992954656},{"date":"2021-01-22","current":-25.238149,"twenty":-36.089914,"median":-31.826947,"eighty":-28.936103,"marketCap":971189210},{"date":"2021-01-29","current":-22.312552,"twenty":-35.97035,"median":-31.754588,"eighty":-28.475809,"marketCap":858609317},{"date":"2021-02-05","current":-21.883465,"twenty":-35.92353,"median":-31.737889,"eighty":-28.025268,"marketCap":842097599},{"date":"2021-02-12","current":-21.727433,"twenty":-35.862817,"median":-31.708982,"eighty":-27.465504,"marketCap":836093338},{"date":"2021-02-19","current":-25.228397,"twenty":-35.799127,"median":-31.653595,"eighty":-26.778963,"marketCap":970813943},{"date":"2021-02-26","current":-23.531551,"twenty":-35.746052,"median":-31.486779,"eighty":-26.086572,"marketCap":905517606},{"date":"2021-03-05","current":-22.390568,"twenty":-35.653171,"median":-31.396293,"eighty":-25.940292,"marketCap":861611447},{"date":"2021-03-12","current":-25.004101,"twenty":-35.638406,"median":-31.225808,"eighty":-25.238149,"marketCap":962182818},{"date":"2021-03-19","current":-21.412757,"twenty":-35.321452,"median":-31.064391,"eighty":-25.004101,"marketCap":949762842},{"date":"2021-03-26","current":-17.828429,"twenty":-35.215302,"median":-30.969768,"eighty":-24.887077,"marketCap":790779984},{"date":"2021-04-01","current":-18.989311,"twenty":-35.024232,"median":-30.680331,"eighty":-24.762252,"marketCap":842270886},{"date":"2021-04-09","current":-18.72663,"twenty":-34.718913,"median":-30.446554,"eighty":-23.687583,"marketCap":830619660},{"date":"2021-04-16","current":-17.582695,"twenty":-34.413171,"median":-30.201646,"eighty":-23.329342,"marketCap":779880450},{"date":"2021-04-23","current":-19.048626,"twenty":-34.331602,"median":-30.09464,"eighty":-22.642588,"marketCap":844901808},{"date":"2021-04-30","current":-19.878228,"twenty":-34.264448,"median":-29.967864,"eighty":-22.388618,"marketCap":881698811},{"date":"2021-05-07","current":-18.504392,"twenty":-33.967825,"median":-29.319357,"eighty":-21.984885,"marketCap":820762289},{"date":"2021-05-14","current":-12.366031,"twenty":-33.808477,"median":-29.222013,"eighty":-21.780094,"marketCap":768103629},{"date":"2021-05-21","current":-13.322854,"twenty":-33.708758,"median":-29.156835,"eighty":-21.678673,"marketCap":827535742},{"date":"2021-05-28","current":-14.37657,"twenty":-33.651075,"median":-29.109689,"eighty":-21.248369,"marketCap":892986296},{"date":"2021-06-04","current":-13.528752,"twenty":-33.48787,"median":-28.982913,"eighty":-20.919439,"marketCap":840324930},{"date":"2021-06-11","current":-15.533236,"twenty":-33.342039,"median":-28.773245,"eighty":-20.304412,"marketCap":964831444},{"date":"2021-06-18","current":-16.235714,"twenty":-33.276359,"median":-28.475809,"eighty":-19.944808,"marketCap":1008465147},{"date":"2021-06-25","current":-17.719396,"twenty":-33.251868,"median":-28.20763,"eighty":-18.985306,"marketCap":1100622536},{"date":"2021-07-02","current":-14.3039,"twenty":-33.243701,"median":-27.69565,"eighty":-18.607999,"marketCap":888472464},{"date":"2021-07-09","current":-15.266779,"twenty":-33.225889,"median":-27.520114,"eighty":-18.486902,"marketCap":948280729},{"date":"2021-07-16","current":-13.777042,"twenty":-33.198433,"median":-27.183671,"eighty":-17.913165,"marketCap":855747187},{"date":"2021-07-23","current":-13.316798,"twenty":-33.073753,"median":-26.730203,"eighty":-17.637375,"marketCap":827159589},{"date":"2021-07-30","current":-11.693832,"twenty":-32.854637,"median":-26.218224,"eighty":-17.10309,"marketCap":726350689},{"date":"2021-08-06","current":-14.746344,"twenty":-32.752871,"median":-26.067068,"eighty":-16.259938,"marketCap":915954440},{"date":"2021-08-13","current":-11.436404,"twenty":-32.71307,"median":-25.872028,"eighty":-15.828761,"marketCap":891021641},{"date":"2021-08-20","current":-11.81156,"twenty":-32.688579,"median":-25.374677,"eighty":-15.39153,"marketCap":920250439},{"date":"2021-08-27","current":-11.881902,"twenty":-32.635144,"median":-25.223521,"eighty":-15.121439,"marketCap":925730839},{"date":"2021-09-03","current":-11.278135,"twenty":-32.554492,"median":-25.004101,"eighty":-14.763154,"marketCap":878690742},{"date":"2021-09-10","current":-13.224258,"twenty":-32.484973,"median":-24.974845,"eighty":-14.543711,"marketCap":1030315132},{"date":"2021-09-17","current":-14.044912,"twenty":-32.416953,"median":-24.862697,"eighty":-14.441383,"marketCap":1094253128},{"date":"2021-09-24","current":-13.734236,"twenty":-32.283367,"median":-24.779805,"eighty":-14.366881,"marketCap":1070048029},{"date":"2021-10-01","current":-13.611137,"twenty":-32.278914,"median":-24.024026,"eighty":-14.14795,"marketCap":1060457330},{"date":"2021-10-08","current":-13.441145,"twenty":-32.243291,"median":-23.531551,"eighty":-14.069443,"marketCap":1047213031},{"date":"2021-10-15","current":-12.614629,"twenty":-32.169819,"median":-23.441741,"eighty":-13.946434,"marketCap":982818335},{"date":"2021-10-22","current":-13.001509,"twenty":-32.160913,"median":-22.956183,"eighty":-13.742797,"marketCap":1012960533},{"date":"2021-10-29","current":-13.189087,"twenty":-32.149781,"median":-22.581778,"eighty":-13.630951,"marketCap":1027574932},{"date":"2021-11-05","current":-15.299341,"twenty":-32.09711,"median":-22.410072,"eighty":-13.655687,"marketCap":1191986921},{"date":"2021-11-12","current":-12.166812,"twenty":-32.063778,"median":-22.346684,"eighty":-13.593676,"marketCap":1164923541},{"date":"2021-11-19","current":-13.7195,"twenty":-32.038459,"median":-22.01024,"eighty":-13.566299,"marketCap":1313587294},{"date":"2021-11-26","current":-11.863131,"twenty":-31.949401,"median":-21.834705,"eighty":-13.499763,"marketCap":1135847350},{"date":"2021-12-03","current":-11.363528,"twenty":-31.871476,"median":-21.771317,"eighty":-13.400112,"marketCap":1088012325},{"date":"2021-12-10","current":-11.936602,"twenty":-31.860343,"median":-21.688425,"eighty":-13.322854,"marketCap":1142881912},{"date":"2021-12-17","current":-11.363528,"twenty":-31.849211,"median":-21.545715,"eighty":-13.25624,"marketCap":1088012325},{"date":"2021-12-23","current":-12.543963,"twenty":-31.8314,"median":-21.349205,"eighty":-13.175019,"marketCap":1201034295},{"date":"2021-12-31","current":-11.642718,"twenty":-31.820188,"median":-20.980345,"eighty":-13.050829,"marketCap":1114743662},{"date":"2022-01-07","current":-9.389605,"twenty":-31.771823,"median":-20.760217,"eighty":-12.953442,"marketCap":899017081},{"date":"2022-01-14","current":-8.733263,"twenty":-31.751248,"median":-20.311191,"eighty":-12.90702,"marketCap":836174989},{"date":"2022-01-21","current":-6.965059,"twenty":-31.742342,"median":-20.064799,"eighty":-12.792452,"marketCap":666876520},{"date":"2022-01-28","current":-7.464662,"twenty":-31.737889,"median":-19.933711,"eighty":-12.673256,"marketCap":714711544},{"date":"2022-02-04","current":-7.969164,"twenty":-31.73121,"median":-19.0217,"eighty":-12.607595,"marketCap":763015540},{"date":"2022-02-11","current":-7.85161,"twenty":-31.718785,"median":-18.924175,"eighty":-12.532803,"marketCap":751760240},{"date":"2022-02-18","current":-7.312822,"twenty":-31.708084,"median":-18.658841,"eighty":-12.451927,"marketCap":700173449},{"date":"2022-02-25","current":-8.013246,"twenty":-31.700282,"median":-18.504392,"eighty":-12.34642,"marketCap":767236277},{"date":"2022-03-04","current":-6.42211,"twenty":-31.661669,"median":-18.41632,"eighty":-12.182486,"marketCap":757866723},{"date":"2022-03-11","current":-7.093861,"twenty":-31.575306,"median":-18.040269,"eighty":-12.09334,"marketCap":837139487},{"date":"2022-03-18","current":-7.478298,"twenty":-31.50577,"median":-17.752167,"eighty":-11.945203,"marketCap":882506430},{"date":"2022-03-25","current":-7.004834,"twenty":-31.476164,"median":-17.582695,"eighty":-11.873443,"marketCap":826633458},{"date":"2022-04-01","current":-8.097442,"twenty":-31.444319,"median":-17.294593,"eighty":-11.825906,"marketCap":955571086},{"date":"2022-04-08","current":-7.988182,"twenty":-31.401121,"median":-16.853967,"eighty":-11.719268,"marketCap":942677323},{"date":"2022-04-14","current":-7.373084,"twenty":-31.365146,"median":-16.296273,"eighty":-11.643698,"marketCap":870090214},{"date":"2022-04-22","current":-6.745845,"twenty":-31.314866,"median":-16.08129,"eighty":-11.54955,"marketCap":796070465},{"date":"2022-04-29","current":-6.030185,"twenty":-31.210223,"median":-15.799693,"eighty":-11.378103,"marketCap":711616090},{"date":"2022-05-06","current":-5.726567,"twenty":-31.14343,"median":-15.63013,"eighty":-11.319167,"marketCap":675786469},{"date":"2022-05-13","current":-5.018968,"twenty":-31.101128,"median":-15.299341,"eighty":-11.132571,"marketCap":644435550},{"date":"2022-05-20","current":-5.018968,"twenty":-30.999044,"median":-15.266779,"eighty":-10.917803,"marketCap":644435550},{"date":"2022-05-27","current":-5.670078,"twenty":-30.980006,"median":-15.085104,"eighty":-10.201035,"marketCap":728038000},{"date":"2022-06-03","current":-5.080979,"twenty":-30.969768,"median":-14.994266,"eighty":-9.134905,"marketCap":652397688},{"date":"2022-06-10","current":-4.918202,"twenty":-30.802785,"median":-14.767356,"eighty":-8.321825,"marketCap":631497076},{"date":"2022-06-17","current":-4.976336,"twenty":-30.680331,"median":-14.582469,"eighty":-8.263048,"marketCap":638961580},{"date":"2022-06-24","current":-5.511176,"twenty":-30.671425,"median":-14.503743,"eighty":-8.133739,"marketCap":707635021},{"date":"2022-07-01","current":-5.991757,"twenty":-30.517801,"median":-14.446601,"eighty":-8.061832,"marketCap":769341591},{"date":"2022-07-08","current":-6.615737,"twenty":-30.439875,"median":-14.434107,"eighty":-8.00322,"marketCap":849460606},{"date":"2022-07-15","current":-6.794017,"twenty":-30.3998,"median":-14.37657,"eighty":-7.922142,"marketCap":872351753},{"date":"2022-07-22","current":-6.418079,"twenty":-30.277345,"median":-14.265264,"eighty":-7.829079,"marketCap":824081291},{"date":"2022-07-29","current":-6.313436,"twenty":-30.149145,"median":-14.128281,"eighty":-7.661565,"marketCap":810645183},{"date":"2022-08-05","current":-7.359862,"twenty":-30.102442,"median":-14.079861,"eighty":-7.498145,"marketCap":945006263},{"date":"2022-08-12","current":-7.744765,"twenty":-30.09464,"median":-14.061667,"eighty":-7.476679,"marketCap":1144188352},{"date":"2022-08-19","current":-7.3884,"twenty":-30.072013,"median":-14.02967,"eighty":-7.470415,"marketCap":1091540050},{"date":"2022-08-26","current":-7.741237,"twenty":-30.00349,"median":-13.904228,"eighty":-7.470415,"marketCap":1143667082},{"date":"2022-09-02","current":-7.501308,"twenty":-29.680657,"median":-13.816405,"eighty":-7.464662,"marketCap":1108220700},{"date":"2022-09-09","current":-7.363701,"twenty":-29.434907,"median":-13.754752,"eighty":-7.442192,"marketCap":1087891157},{"date":"2022-09-16","current":-7.349588,"twenty":-29.326183,"median":-13.669756,"eighty":-7.391986,"marketCap":1085806076},{"date":"2022-09-23","current":-6.541592,"twenty":-29.285225,"median":-13.638908,"eighty":-7.361398,"marketCap":966435173},{"date":"2022-09-30","current":-5.761823,"twenty":-29.25994,"median":-13.589311,"eighty":-7.336663,"marketCap":851234432},{"date":"2022-10-07","current":-5.779465,"twenty":-29.212191,"median":-13.561735,"eighty":-7.29548,"marketCap":853840784},{"date":"2022-10-14","current":-5.79005,"twenty":-29.181854,"median":-13.499763,"eighty":-7.22525,"marketCap":855404595},{"date":"2022-10-21","current":-5.020866,"twenty":-29.157157,"median":-13.418819,"eighty":-7.180208,"marketCap":741767665},{"date":"2022-10-28","current":-5.130245,"twenty":-29.152611,"median":-13.388388,"eighty":-7.120264,"marketCap":757927045},{"date":"2022-11-04","current":-4.784465,"twenty":-29.133094,"median":-13.325882,"eighty":-7.077936,"marketCap":706842553},{"date":"2022-11-11","current":-4.987127,"twenty":-29.082383,"median":-13.286519,"eighty":-7.007322,"marketCap":808223767},{"date":"2022-11-18","current":-4.076405,"twenty":-29.01802,"median":-13.240249,"eighty":-6.959181,"marketCap":660630343},{"date":"2022-11-25","current":-4.210829,"twenty":-28.971211,"median":-13.206672,"eighty":-6.908542,"marketCap":682415350},{"date":"2022-12-02","current":-3.908375,"twenty":-28.895145,"median":-13.107021,"eighty":-6.819609,"marketCap":633399084},{"date":"2022-12-09","current":-3.666412,"twenty":-28.776171,"median":-13.032334,"eighty":-6.759911,"marketCap":594186071},{"date":"2022-12-16","current":-7.552337,"twenty":-28.709857,"median":-12.972199,"eighty":-6.729659,"marketCap":1223946832},{"date":"2022-12-23","current":-8.569155,"twenty":-28.475809,"median":-12.939832,"eighty":-6.746629,"marketCap":1388734462},{"date":"2022-12-30","current":-9.098065,"twenty":-28.475809,"median":-12.916512,"eighty":-6.749766,"marketCap":1474450608},{"date":"2023-01-06","current":-8.130447,"twenty":-28.468007,"median":-12.870801,"eighty":-6.757262,"marketCap":1317636573},{"date":"2023-01-13","current":-9.286668,"twenty":-28.349034,"median":-12.790483,"eighty":-6.762237,"marketCap":1505016056},{"date":"2023-01-20","current":-9.212867,"twenty":-28.1852,"median":-12.679109,"eighty":-6.781615,"marketCap":1493055663},{"date":"2023-01-27","current":-9.622875,"twenty":-28.042821,"median":-12.668823,"eighty":-6.805644,"marketCap":1559502288},{"date":"2023-02-03","current":-9.90988,"twenty":-27.820476,"median":-12.614629,"eighty":-6.815441,"marketCap":1606014926},{"date":"2023-02-10","current":-9.319469,"twenty":-27.596211,"median":-12.557946,"eighty":-6.825218,"marketCap":1510331786},{"date":"2023-02-17","current":-10.516691,"twenty":-27.524036,"median":-12.524371,"eighty":-6.862225,"marketCap":1704355931},{"date":"2023-02-24","current":-9.335869,"twenty":-27.492809,"median":-12.493203,"eighty":-6.889742,"marketCap":1512989651},{"date":"2023-03-03","current":-10.035487,"twenty":-27.440149,"median":-12.425244,"eighty":-6.901778,"marketCap":1746124614},{"date":"2023-03-10","current":-8.354767,"twenty":-27.231456,"median":-12.333346,"eighty":-6.912071,"marketCap":1453687685},{"date":"2023-03-17","current":-8.346628,"twenty":-26.878433,"median":-12.20808,"eighty":-6.923154,"marketCap":1452271526},{"date":"2023-03-24","current":-8.15129,"twenty":-26.759459,"median":-12.160132,"eighty":-6.936445,"marketCap":1418283699},{"date":"2023-03-31","current":-6.246745,"twenty":-26.718501,"median":-12.09334,"eighty":-6.923154,"marketCap":1086902385},{"date":"2023-04-06","current":-5.514228,"twenty":-26.630733,"median":-12.022319,"eighty":-6.88645,"marketCap":959448034},{"date":"2023-04-14","current":-6.210119,"twenty":-26.297215,"median":-11.936602,"eighty":-6.814077,"marketCap":1080529667},{"date":"2023-04-21","current":-6.409527,"twenty":-26.086572,"median":-11.881733,"eighty":-6.75164,"marketCap":1115225574},{"date":"2023-04-28","current":-5.921182,"twenty":-26.082671,"median":-11.863131,"eighty":-6.746629,"marketCap":1030256007},{"date":"2023-05-05","current":-4.55822,"twenty":-26.057316,"median":-11.826396,"eighty":-6.654268,"marketCap":793107504},{"date":"2023-05-12","current":-4.123772,"twenty":-26.002705,"median":-11.770068,"eighty":-6.61586,"marketCap":792399372},{"date":"2023-05-19","current":-3.939845,"twenty":-25.912986,"median":-11.705944,"eighty":-6.582075,"marketCap":757056927},{"date":"2023-05-26","current":-4.028298,"twenty":-25.768657,"median":-11.642718,"eighty":-6.532696,"marketCap":774053528},{"date":"2023-06-02","current":-4.006185,"twenty":-25.628229,"median":-11.606396,"eighty":-6.507219,"marketCap":769804377},{"date":"2023-06-09","current":-4.38211,"twenty":-25.425387,"median":-11.536054,"eighty":-6.447533,"marketCap":842039931},{"date":"2023-06-16","current":-4.599557,"twenty":-25.265455,"median":-11.451058,"eighty":-6.417304,"marketCap":883823241},{"date":"2023-06-23","current":-4.297342,"twenty":-25.232298,"median":-11.363528,"eighty":-6.355731,"marketCap":825751522},{"date":"2023-06-30","current":-4.087266,"twenty":-25.224496,"median":-11.343275,"eighty":-6.280747,"marketCap":785384595},{"date":"2023-07-07","current":-3.973015,"twenty":-25.19329,"median":-11.29572,"eighty":-6.217444,"marketCap":763430652},{"date":"2023-07-14","current":-4.083581,"twenty":-25.074315,"median":-11.149175,"eighty":-6.034901,"marketCap":784676403},{"date":"2023-07-21","current":-3.718712,"twenty":-25.0002,"median":-11.00556,"eighty":-5.918732,"marketCap":714565425},{"date":"2023-07-28","current":-3.353844,"twenty":-24.982647,"median":-10.912905,"eighty":-5.893783,"marketCap":644454447},{"date":"2023-08-04","current":-3.449668,"twenty":-24.963143,"median":-10.690816,"eighty":-5.812632,"marketCap":662867431},{"date":"2023-08-11","current":-3.431213,"twenty":-24.910482,"median":-10.45519,"eighty":-5.790085,"marketCap":663902014},{"date":"2023-08-18","current":-3.15932,"twenty":-24.877325,"median":-10.098356,"eighty":-5.73622,"marketCap":611293707},{"date":"2023-08-25","current":-3.036777,"twenty":-24.830515,"median":-9.963181,"eighty":-5.694292,"marketCap":587582921},{"date":"2023-09-01","current":-2.895086,"twenty":-24.795408,"median":-9.92423,"eighty":-5.645386,"marketCap":560167324},{"date":"2023-09-08","current":-2.657658,"twenty":-24.779805,"median":-9.89937,"eighty":-5.620688,"marketCap":514227676},{"date":"2023-09-15","current":-2.79169,"twenty":-24.692038,"median":-9.799178,"eighty":-5.507781,"marketCap":540161349},{"date":"2023-09-22","current":-2.665317,"twenty":-24.321462,"median":-9.686426,"eighty":-5.398782,"marketCap":515709600},{"date":"2023-09-29","current":-2.512138,"twenty":-23.726591,"median":-9.659775,"eighty":-5.29414,"marketCap":486071117},{"date":"2023-10-06","current":-2.385765,"twenty":-23.726591,"median":-9.633125,"eighty":-5.197248,"marketCap":461619369},{"date":"2023-10-13","current":-2.339812,"twenty":-23.531551,"median":-9.508072,"eighty":-5.09849,"marketCap":452727824},{"date":"2023-10-20","current":-2.113872,"twenty":-23.531551,"median":-9.377088,"eighty":-5.020866,"marketCap":409011062},{"date":"2023-10-27","current":-2.021965,"twenty":-23.52765,"median":-9.35022,"eighty":-5.018968,"marketCap":391227972},{"date":"2023-11-03","current":-1.937716,"twenty":-23.457752,"median":-9.319469,"eighty":-4.995462,"marketCap":374926807},{"date":"2023-11-10","current":-2.007807,"twenty":-23.297002,"median":-9.252089,"eighty":-4.97662,"marketCap":406074871},{"date":"2023-11-17","current":-2.172681,"twenty":-23.102463,"median":-9.208767,"eighty":-4.944556,"marketCap":439420436},{"date":"2023-11-24","current":-2.293589,"twenty":-22.944481,"median":-9.098065,"eighty":-4.9058,"marketCap":463873850},{"date":"2023-12-01","current":-2.861491,"twenty":-22.854762,"median":-9.062046,"eighty":-4.817675,"marketCap":578730793},{"date":"2023-12-08","current":-2.949424,"twenty":-22.642588,"median":-9.020164,"eighty":-4.736046,"marketCap":596515094},{"date":"2023-12-15","current":-2.942096,"twenty":-22.478734,"median":-8.888495,"eighty":-4.694967,"marketCap":595033069},{"date":"2023-12-22","current":-3.326804,"twenty":-22.459579,"median":-8.782359,"eighty":-4.625203,"marketCap":672839386},{"date":"2023-12-29","current":-3.418401,"twenty":-22.422449,"median":-8.716971,"eighty":-4.575798,"marketCap":691364699},{"date":"2024-01-05","current":-3.605259,"twenty":-22.40227,"median":-8.619287,"eighty":-4.546011,"marketCap":729156339},{"date":"2024-01-12","current":-4.121866,"twenty":-22.386667,"median":-8.480923,"eighty":-4.474248,"marketCap":833639107},{"date":"2024-01-19","current":-3.821428,"twenty":-22.367163,"median":-8.410527,"eighty":-4.373264,"marketCap":772876079},{"date":"2024-01-26","current":-4.11118,"twenty":-22.291896,"median":-8.346628,"eighty":-4.316264,"marketCap":831478023},{"date":"2024-02-02","current":-4.766927,"twenty":-22.169467,"median":-8.324274,"eighty":-4.333222,"marketCap":964101547},{"date":"2024-02-09","current":-4.912213,"twenty":-21.984885,"median":-8.302651,"eighty":-4.337146,"marketCap":993485202},{"date":"2024-02-16","current":-5.312729,"twenty":-21.873713,"median":-8.279699,"eighty":-4.353363,"marketCap":1074488792},{"date":"2024-02-23","current":-5.709318,"twenty":-21.834705,"median":-8.254149,"eighty":-4.371053,"marketCap":1154698229},{"date":"2024-03-01","current":-6.884704,"twenty":-21.815201,"median":-8.220472,"eighty":-4.38211,"marketCap":1461071871},{"date":"2024-03-08","current":-7.531791,"twenty":-21.785945,"median":-8.189978,"eighty":-4.452135,"marketCap":1598396659},{"date":"2024-03-15","current":-9.017834,"twenty":-21.756689,"median":-8.204249,"eighty":-4.466877,"marketCap":1913764632},{"date":"2024-03-22","current":-9.066741,"twenty":-21.727433,"median":-8.229515,"eighty":-4.485305,"marketCap":1924143831},{"date":"2024-03-28","current":-9.281183,"twenty":-21.696227,"median":-8.254149,"eighty":-4.491202,"marketCap":1969652627},{"date":"2024-04-05","current":-10.661495,"twenty":-21.680623,"median":-8.292436,"eighty":-4.519064,"marketCap":2262582364},{"date":"2024-04-12","current":-11.408564,"twenty":-21.678673,"median":-8.304891,"eighty":-4.535429,"marketCap":2421125493},{"date":"2024-04-19","current":-10.368967,"twenty":-21.46594,"median":-8.326723,"eighty":-4.55415,"marketCap":2200502223},{"date":"2024-04-26","current":-10.7245,"twenty":-21.412757,"median":-8.350698,"eighty":-4.564979,"marketCap":2275953471},{"date":"2024-05-03","current":-11.526166,"twenty":-21.311074,"median":-8.417453,"eighty":-4.569664,"marketCap":2446082844},{"date":"2024-05-10","current":-12.211067,"twenty":-21.136518,"median":-8.528949,"eighty":-4.570559,"marketCap":2591432567},{"date":"2024-05-17","current":-12.011,"twenty":-21.004123,"median":-8.619287,"eighty":-4.575834,"marketCap":2746687402},{"date":"2024-05-24","current":-11.488237,"twenty":-20.980345,"median":-8.728825,"eighty":-4.595074,"marketCap":2627141467},{"date":"2024-05-31","current":-11.316771,"twenty":-20.888986,"median":-8.784409,"eighty":-4.609363,"marketCap":2587930400},{"date":"2024-06-07","current":-10.890196,"twenty":-20.746644,"median":-8.909462,"eighty":-4.626414,"marketCap":2490380917},{"date":"2024-06-14","current":-16.711683,"twenty":-20.65513,"median":-8.938982,"eighty":-4.645017,"marketCap":3821644450},{"date":"2024-06-21","current":-17.463994,"twenty":-20.541673,"median":-9.002785,"eighty":-4.663959,"marketCap":3993683592},{"date":"2024-06-28","current":-18.824523,"twenty":-20.426432,"median":-9.017834,"eighty":-4.66706,"marketCap":4304810763},{"date":"2024-07-05","current":-17.278256,"twenty":-20.304412,"median":-9.028364,"eighty":-4.67213,"marketCap":3951208893},{"date":"2024-07-12","current":-20.575102,"twenty":-20.304412,"median":-9.060735,"eighty":-4.682062,"marketCap":4705134803},{"date":"2024-07-15","current":-20.80263,"twenty":-20.416755,"median":-9.066741,"eighty":-4.685549,"marketCap":4757166310},{"date":"2024-08-02","current":-20.695831,"twenty":-20.57994,"median":-9.068053,"eighty":-4.689037,"marketCap":4732743358},{"date":"2024-08-09","current":-19.442101,"twenty":-20.389364,"median":-9.098065,"eighty":-4.702292,"marketCap":4446039138},{"date":"2024-08-16","current":-21.104668,"twenty":-20.45155,"median":-9.161017,"eighty":-4.704816,"marketCap":5327852349},{"date":"2024-08-23","current":-19.882184,"twenty":-20.693049,"median":-9.212867,"eighty":-4.711267,"marketCap":5019237468},{"date":"2024-08-30","current":-19.782437,"twenty":-20.617905,"median":-9.283926,"eighty":-4.724704,"marketCap":4994056368},{"date":"2024-09-06","current":-18.910228,"twenty":-20.584778,"median":-9.305118,"eighty":-4.728041,"marketCap":4773868141},{"date":"2024-09-13","current":-19.165395,"twenty":-20.528184,"median":-9.335869,"eighty":-4.751474,"marketCap":4838284910},{"date":"2024-09-20","current":-21.178899,"twenty":-20.584778,"median":-9.377088,"eighty":-4.766927,"marketCap":5346591773},{"date":"2024-09-27","current":-19.564385,"twenty":-20.614011,"median":-9.508072,"eighty":-4.767001,"marketCap":4939009311},{"date":"2024-10-04","current":-21.828416,"twenty":-20.69977,"median":-9.611919,"eighty":-4.777499,"marketCap":5510561728},{"date":"2024-10-11","current":-20.515463,"twenty":-20.808388,"median":-9.644811,"eighty":-4.795146,"marketCap":5179108175},{"date":"2024-10-18","current":-22.510409,"twenty":-20.924108,"median":-9.672717,"eighty":-4.8043,"marketCap":5682730182},{"date":"2024-10-25","current":-20.946928,"twenty":-21.062913,"median":-9.717176,"eighty":-4.807671,"marketCap":5288031074},{"date":"2024-10-31","current":-20.051522,"twenty":-21.062913,"median":-9.811478,"eighty":-4.820452,"marketCap":5061986778},{"date":"2024-11-08","current":-19.838416,"twenty":-21.062913,"median":-9.907571,"eighty":-4.84349,"marketCap":5564437571},{"date":"2024-11-15","current":-21.255407,"twenty":-21.084706,"median":-9.93858,"eighty":-4.869368,"marketCap":5961886570},{"date":"2024-11-22","current":-18.103464,"twenty":-21.062913,"median":-9.999334,"eighty":-4.898048,"marketCap":5077804531},{"date":"2024-11-29","current":-18.303385,"twenty":-21.046399,"median":-10.098356,"eighty":-4.902699,"marketCap":5133879910},{"date":"2024-12-06","current":-15.687401,"twenty":-20.980345,"median":-10.127184,"eighty":-4.904602,"marketCap":4400127610},{"date":"2024-12-13","current":-14.360267,"twenty":-20.973662,"median":-10.412078,"eighty":-4.913411,"marketCap":4027882541},{"date":"2024-12-20","current":-13.207532,"twenty":-20.943217,"median":-10.598489,"eighty":-4.922504,"marketCap":3704554292},{"date":"2024-12-27","current":-13.237308,"twenty":-20.928371,"median":-10.661495,"eighty":-4.939713,"marketCap":3712905945},{"date":"2025-01-03","current":-13.262829,"twenty":-20.920948,"median":-10.736574,"eighty":-4.941107,"marketCap":3720064504},{"date":"2025-01-10","current":-12.731125,"twenty":-20.899606,"median":-10.760504,"eighty":-4.946106,"marketCap":3570927857},{"date":"2025-01-17","current":-12.033529,"twenty":-20.875481,"median":-10.849125,"eighty":-4.95057,"marketCap":3375260577},{"date":"2025-01-24","current":-12.816198,"twenty":-20.852067,"median":-10.87291,"eighty":-4.952418,"marketCap":3594789721},{"date":"2025-01-31","current":-13.879606,"twenty":-20.823658,"median":-10.890196,"eighty":-4.960884,"marketCap":3893063013},{"date":"2025-02-07","current":-14.934507,"twenty":-20.811267,"median":-10.956919,"eighty":-4.973416,"marketCap":4188950119},{"date":"2025-02-14","current":-14.045498,"twenty":-20.799109,"median":-11.007295,"eighty":-4.97662,"marketCap":3939593647},{"date":"2025-02-21","current":-13.83707,"twenty":-20.776198,"median":-11.084534,"eighty":-4.979061,"marketCap":3881132082},{"date":"2025-02-28","current":-10.764795,"twenty":-20.703709,"median":-11.126407,"eighty":-4.987294,"marketCap":3469514938},{"date":"2025-03-07","current":-11.319953,"twenty":-20.695136,"median":-11.124394,"eighty":-4.988898,"marketCap":3648443335},{"date":"2025-03-14","current":-11.983857,"twenty":-20.689452,"median":-11.128498,"eighty":-4.99405,"marketCap":3862421231},{"date":"2025-03-21","current":-11.498983,"twenty":-20.669492,"median":-11.149175,"eighty":-5.000402,"marketCap":3706145239},{"date":"2025-03-28","current":-12.144239,"twenty":-20.628729,"median":-11.183518,"eighty":-5.004574,"marketCap":3914112520},{"date":"2025-04-04","current":-10.480747,"twenty":-20.594455,"median":-11.15204,"eighty":-5.011771,"marketCap":3377965658},{"date":"2025-04-11","current":-8.992555,"twenty":-20.563174,"median":-11.12911,"eighty":-5.018968,"marketCap":2898318577},{"date":"2025-04-17","current":-9.607973,"twenty":-20.515463,"median":-11.126407,"eighty":-5.018968,"marketCap":3096668873},{"date":"2025-04-25","current":-11.536281,"twenty":-20.496906,"median":-11.124394,"eighty":-5.020866,"marketCap":3718166469},{"date":"2025-05-02","current":-12.192726,"twenty":-20.420662,"median":-11.12911,"eighty":-5.038508,"marketCap":3929740119},{"date":"2025-05-09","current":-9.341019,"twenty":-20.413396,"median":-11.128576,"eighty":-5.046601,"marketCap":3448890915},{"date":"2025-05-16","current":-9.457766,"twenty":-20.413396,"median":-11.114009,"eighty":-5.080979,"marketCap":3491996260},{"date":"2025-05-23","current":-10.058466,"twenty":-20.390199,"median":-11.032758,"eighty":-5.09849,"marketCap":3713786840},{"date":"2025-05-30","current":-10.349022,"twenty":-20.352383,"median":-11.021568,"eighty":-5.118249,"marketCap":3821065980},{"date":"2025-06-06","current":-11.618981,"twenty":-20.317539,"median":-11.026753,"eighty":-5.128834,"marketCap":4289960196},{"date":"2025-06-11","current":-10.97584,"twenty":-20.292093,"median":-11.015974,"eighty":-5.130468,"marketCap":4052499629}],"updateTime":1749780432898}}}